I-Mab
NASDAQ:IMAB

Watchlist Manager
I-Mab Logo
I-Mab
NASDAQ:IMAB
Watchlist
Price: 0.99 USD -5.71% Market Closed
Market Cap: 80.1m USD

Wall Street
Price Targets

IMAB Price Targets Summary
I-Mab

Wall Street analysts forecast IMAB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IMAB is 5.61 USD with a low forecast of 4.04 USD and a high forecast of 7.35 USD.

Lowest
Price Target
4.04 USD
308% Upside
Average
Price Target
5.61 USD
467% Upside
Highest
Price Target
7.35 USD
642% Upside
I-Mab Competitors:
Price Targets
688293
Shanghai OPM Biosciences Co Ltd
33% Upside
300601
Shenzhen Kangtai Biological Products Co Ltd
29% Upside
OPK
OPKO Health Inc
223% Upside
FYB
Formycon AG
156% Upside
IMNM
Immunome Inc
184% Upside
MAAT
Maat Pharma SA
278% Upside
ALNY
Alnylam Pharmaceuticals Inc
14% Upside
MRUS
Merus NV
58% Upside

Revenue
Forecast

Revenue Estimate
I-Mab

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
I-Mab

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
I-Mab

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IMAB's stock price target?
Price Target
5.61 USD

According to Wall Street analysts, the average 1-year price target for IMAB is 5.61 USD with a low forecast of 4.04 USD and a high forecast of 7.35 USD.

Back to Top